This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
An HIV-1 gp41 peptide-liposome vaccine elicits neutralizing epitope-targeted antibody responses in healthy individuals.
medRxiv : the preprint server for health sciences
Citation
Erdmann, Nathaniel; Williams, Wilton B; Walsh, Stephen R; Cain, Derek W; Clark, Matthew; Tuck, Ryan; Holmes, Sommer; Clardy, Benae; Foulger, Andrew; Parks, Robert; Barr, Margaret; Eaton, Amanda; Saunders, Kevin O; Grunenberg, Nicole; Edlefsen, Paul; Goepfert, Paul A; Cohen, Kristen W; Maenza, Janine; Mayer, Kenneth; Van Tieu, Hong; Sobieszczyk, Magdalena E; Swann, Edith; Lu, Huiyin; De Rosa, Stephen C; Sagawa, Zachary K; Lin, Bob C; Carrol, Robin E; McKee, Krisha; Doria-Rose, Nicole A; Louder, Mark K; Moody, M Anthony; Fox, Christopher B; Ferrari, Guido; Edwards, Robert J; Acharya, Priyamvada; Alam, S Munir; Tomaras, Georgia D; Montefiori, David C; Gilbert, Peter B; McElrath, M Juliana; Corey, Lawrence; Haynes, Barton F; Baden, Lindsey R. (2025). An HIV-1 gp41 peptide-liposome vaccine elicits neutralizing epitope-targeted antibody responses in healthy individuals.. medRxiv : the preprint server for health sciences. https://doi.org/10.1101/2024.03.15.24304305